TreeWAS – Variant ID: rs13278529

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
G91.9 Hydrocephalus, unspecified	0.032	0.968	0.000
G91 Hydrocephalus	0.026	0.974	0.000
G91.2 Normal-pressure hydrocephalus	0.023	0.977	0.000
G91.8 Other hydrocephalus	0.021	0.979	0.000
G91.3 Posttraumatic hydrocephalus, unspecified	0.019	0.981	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.018	0.982	0.000
G91.1 Obstructive hydrocephalus	0.018	0.982	0.000
G91.0 Communicating hydrocephalus	0.017	0.982	0.000
G90-G99 Other disorders of the nervous system	0.017	0.983	0.000
G90 Disorders of autonomic nervous system	0.014	0.986	0.000
G98 Other disorders of nervous system, not elsewhere classified	0.014	0.986	0.000
G94 Other disorders of brain in diseases classified elsewhere	0.013	0.987	0.000
G90.9 Disorder of autonomic nervous system, unspecified	0.013	0.987	0.000
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.013	0.987	0.000
G99 Other disorders of nervous system in diseases classified elsewhere	0.012	0.988	0.000
G92 Toxic encephalopathy	0.012	0.988	0.000
G90.3 Multisystem degeneration	0.012	0.988	0.000
G90.0 Idiopathic peripheral autonomic neuropathy	0.011	0.988	0.000
G96 Other disorders of central nervous system	0.011	0.989	0.000
N83.0 Follicular cyst of ovary	0.000	0.989	0.011
G90.8 Other disorders of autonomic nervous system	0.010	0.989	0.000
G90.4 Autonomic dysreflexia	0.010	0.989	0.000
G90.1 Familial dysautonomia [Riley-Day]	0.010	0.989	0.000
G94.2 Hydrocephalus in other diseases classified elsewhere	0.010	0.990	0.000
G97.0 Cerebrospinal fluid leak from spinal puncture	0.010	0.990	0.000
G94.1 Hydrocephalus in neoplastic disease	0.010	0.990	0.000
G95 Other diseases of spinal cord	0.010	0.990	0.000
G97.1 Other reaction to spinal and lumbar puncture	0.010	0.990	0.000
G99.2 Myelopathy in diseases classified elsewhere	0.010	0.990	0.000
G94.8 Other specified disorders of brain in diseases classified elsewhere	0.009	0.990	0.000
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere	0.009	0.990	0.000
G96.8 Other specified disorders of central nervous system	0.009	0.991	0.000
G97.9 Postprocedural disorder of nervous system, unspecified	0.009	0.991	0.000
G97.2 Intracranial hypotension following ventricular shunting	0.009	0.991	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.009	0.991	0.000
G99.8 Other specified disorders of nervous system in diseases classified elsewhere	0.009	0.991	0.000
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere	0.009	0.991	0.000
G97.8 Other postprocedural disorders of nervous system	0.009	0.991	0.000
G00-G09 Inflammatory diseases of the central nervous system	0.009	0.991	0.000
G96.1 Disorders of meninges, not elsewhere classified	0.009	0.991	0.000
Y43.4 Immunosuppressive agents	0.009	0.991	0.000
Y52 Agents primarily affecting the cardiovascular system	0.008	0.992	0.000
G20-G26 Extrapyramidal and movement disorders	0.008	0.992	0.000
G96.9 Disorder of central nervous system, unspecified	0.008	0.992	0.000
Y52.1 Calcium-channel blockers	0.008	0.992	0.000
G30.9 Alzheimer's disease, unspecified	0.008	0.992	0.000
G25 Other extrapyramidal and movement disorders	0.008	0.992	0.000
Chapter VI Diseases of the nervous system	0.008	0.992	0.000
G24 Dystonia	0.008	0.992	0.000
G30 Alzheimer's disease	0.008	0.992	0.000
G25.8 Other specified extrapyramidal and movement disorders	0.008	0.992	0.000
G99.0 Autonomic neuropathy in endocrine and metabolic diseases	0.008	0.992	0.000
G90.2 Horner's syndrome	0.008	0.992	0.000
G30-G32 Other degenerative diseases of the nervous system	0.008	0.992	0.000
G95.1 Vascular myelopathies	0.008	0.992	0.000
G95.0 Syringomyelia and syringobulbia	0.008	0.992	0.000
G24.3 Spasmodic torticollis	0.008	0.992	0.000
X49.9 Unspecified place	0.008	0.992	0.000
G08 Intracranial and intraspinal phlebitis and thrombophlebitis	0.008	0.992	0.000
G04 Encephalitis, myelitis and encephalomyelitis	0.007	0.992	0.000
G09 Sequelae of inflammatory diseases of central nervous system	0.007	0.992	0.000
Y43 Primarily systemic agents	0.008	0.992	0.000
G00 Bacterial meningitis, not elsewhere classified	0.007	0.993	0.000
X49 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances	0.007	0.993	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.007	0.993	0.000
G24.5 Blepharospasm	0.007	0.993	0.000
G25.5 Other chorea	0.007	0.993	0.000
G02 Meningitis in other infectious and parasitic diseases classified elsewhere	0.007	0.993	0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.007	0.993	0.000
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere	0.007	0.993	0.000
G30.0 Alzheimer's disease with early onset	0.007	0.993	0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.993	0.007
G25.0 Essential tremor	0.007	0.993	0.000
G95.8 Other specified diseases of spinal cord	0.007	0.993	0.000
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.000	0.993	0.007
X40-X49 Accidental poisoning by and exposure to noxious substances	0.007	0.993	0.000
G01 Meningitis in bacterial diseases classified elsewhere	0.007	0.993	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.007	0.993	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.007	0.993	0.000
G11 Hereditary ataxia	0.006	0.993	0.000
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere	0.006	0.993	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.006	0.993	0.000
G24.9 Dystonia, unspecified	0.006	0.994	0.000
G00.1 Pneumococcal meningitis	0.006	0.994	0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified	0.006	0.994	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.006	0.994	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.006	0.994	0.000
Y52.7 Peripheral vasodilators	0.006	0.994	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.006	0.994	0.000
G23 Other degenerative diseases of basal ganglia	0.006	0.994	0.000
G21 Secondary Parkinsonism	0.006	0.994	0.000
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.006	0.994	0.000
G22 Parkinsonism in diseases classified elsewhere	0.006	0.994	0.000
G95.2 Cord compression, unspecified	0.006	0.994	0.000
F00 Dementia in Alzheimer's disease	0.006	0.994	0.000
Y43.1 Antineoplastic antimetabolites	0.006	0.994	0.000
G80-G83 Cerebral palsy and other paralytic syndromes	0.006	0.994	0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.006	0.994	0.000
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.994	0.006
G25.9 Extrapyramidal and movement disorder, unspecified	0.006	0.994	0.000
G25.6 Drug-induced tics and other tics of organic origin	0.006	0.994	0.000
G25.4 Drug-induced chorea	0.006	0.994	0.000
G25.2 Other specified forms of tremor	0.006	0.994	0.000
G25.1 Drug-induced tremor	0.006	0.994	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.006	0.994	0.000
G04.8 Other encephalitis, myelitis and encephalomyelitis	0.006	0.994	0.000
G24.4 Idiopathic orofacial dystonia	0.006	0.994	0.000
G24.2 Idiopathic nonfamilial dystonia	0.006	0.994	0.000
G24.1 Idiopathic familial dystonia	0.006	0.994	0.000
G24.0 Drug-induced dystonia	0.006	0.994	0.000
G30.8 Other Alzheimer's disease	0.006	0.994	0.000
G30.1 Alzheimer's disease with late onset	0.006	0.994	0.000
G95.9 Disease of spinal cord, unspecified	0.006	0.994	0.000
G11.4 Hereditary spastic paraplegia	0.006	0.994	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.006	0.994	0.000
Y40 Systemic antibiotics	0.006	0.994	0.000
G03 Meningitis due to other and unspecified causes	0.006	0.994	0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.006	0.994	0.000
Y59 Other and unspecified vaccines and biological substances	0.006	0.994	0.000
G24.8 Other dystonia	0.006	0.994	0.000
X49.6 Industrial and construction area	0.006	0.994	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.006	0.994	0.000
Y43.0 Antiallergic and antiemetic drugs	0.006	0.994	0.000
F00.0 Dementia in Alzheimer's disease with early onset	0.006	0.994	0.000
Y48 Anaesthetics and therapeutic gases	0.006	0.994	0.000
X42 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.006	0.994	0.000
G80 Infantile cerebral palsy	0.006	0.994	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.006	0.994	0.000
G82 Paraplegia and tetraplegia	0.006	0.994	0.000
G00.9 Bacterial meningitis, unspecified	0.006	0.994	0.000
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified	0.006	0.994	0.000
G04.1 Tropical spastic paraplegia	0.006	0.994	0.000
G04.0 Acute disseminated encephalitis	0.006	0.994	0.000
J95.8 Other postprocedural respiratory disorders	0.006	0.994	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.006	0.994	0.000
Y43.9 Primarily systemic agent, unspecified	0.006	0.994	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.006	0.994	0.000
Y43.6 Enzymes, not elsewhere classified	0.006	0.994	0.000
Y43.5 Acidifying and alkalising agents	0.006	0.994	0.000
Y43.2 Antineoplastic natural products	0.006	0.994	0.000
G11.1 Early-onset cerebellar ataxia	0.006	0.994	0.000
Y40.9 Systemic antibiotic, unspecified	0.006	0.994	0.000
G00.8 Other bacterial meningitis	0.005	0.994	0.000
G00.3 Staphylococcal meningitis	0.005	0.994	0.000
G00.2 Streptococcal meningitis	0.005	0.994	0.000
G00.0 Haemophilus meningitis	0.005	0.994	0.000
G02.0 Meningitis in viral diseases classified elsewhere	0.005	0.994	0.000
G25.3 Myoclonus	0.005	0.994	0.000
G96.0 Cerebrospinal fluid leak	0.005	0.994	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.005	0.994	0.000
X60-X84 Intentional self-harm	0.006	0.994	0.000
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere	0.005	0.994	0.000
G06 Intracranial and intraspinal abscess and granuloma	0.005	0.994	0.000
Chapter XX External causes of morbidity and mortality	0.006	0.994	0.000
X41.9 Unspecified place	0.005	0.995	0.000
X49.4 Street and highway	0.005	0.995	0.000
X49.0 Home	0.005	0.995	0.000
X49.8 Other specified place	0.005	0.995	0.000
X49.7 Farm	0.005	0.995	0.000
X49.5 Trade and service area	0.005	0.995	0.000
X49.3 Sports and athletics area	0.005	0.995	0.000
X49.2 School, other institution and public administrative area	0.005	0.995	0.000
X49.1 Residential institution	0.005	0.995	0.000
Y58 Bacterial vaccines	0.005	0.995	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.005	0.995	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.005	0.995	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
X78 Intentional self-harm by sharp object	0.005	0.995	0.000
X78.0 Home	0.005	0.995	0.000
Y40.8 Other systemic antibiotics	0.005	0.995	0.000
Y40.3 Macrolides	0.005	0.995	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.005	0.995	0.000
G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere	0.005	0.995	0.000
G02.1 Meningitis in mycoses	0.005	0.995	0.000
G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere	0.005	0.995	0.000
G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere	0.005	0.995	0.000
G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere	0.005	0.995	0.000
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere	0.005	0.995	0.000
G14 Postpolio syndrome	0.005	0.995	0.000
G10 Huntington's disease	0.005	0.995	0.000
Y54.5 Other diuretics	0.005	0.995	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.005	0.995	0.000
X42.2 School, other institution and public administrative area	0.005	0.995	0.000
Y59.3 Immunoglobulin	0.005	0.995	0.000
X48 Accidental poisoning by and exposure to pesticides	0.005	0.995	0.000
X46 Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.005	0.995	0.000
X44 Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
X43 Accidental poisoning by and exposure to other drugs acting on the autonomic nervous system	0.005	0.995	0.000
X40 Accidental poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.005	0.995	0.000
G82.1 Spastic paraplegia	0.005	0.995	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.005	0.995	0.000
G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere	0.005	0.995	0.000
G11.9 Hereditary ataxia, unspecified	0.005	0.995	0.000
G80.9 Infantile cerebral palsy, unspecified	0.005	0.995	0.000
Z82.0 Family history of epilepsy and other diseases of the nervous system	0.005	0.995	0.000
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.000	0.995	0.005
O26.9 Pregnancy-related condition, unspecified	0.005	0.995	0.000
G11.8 Other hereditary ataxias	0.005	0.995	0.000
G11.3 Cerebellar ataxia with defective DNA repair	0.005	0.995	0.000
G11.2 Late-onset cerebellar ataxia	0.005	0.995	0.000
G11.0 Congenital nonprogressive ataxia	0.005	0.995	0.000
D36.7 Other specified sites	0.000	0.995	0.005
G93 Other disorders of brain	0.005	0.995	0.000
W75-W84 Other accidental threats to breathing	0.005	0.995	0.000
X47 Accidental poisoning by and exposure to other gases and vapours	0.005	0.995	0.000
I95.1 Orthostatic hypotension	0.005	0.995	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.005	0.995	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
W20-W49 Exposure to inanimate mechanical forces	0.005	0.995	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.005	0.995	0.000
V10-V19 Pedal cyclist injured in transport accident	0.005	0.995	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.000	0.995	0.005
G21.9 Secondary Parkinsonism, unspecified	0.004	0.995	0.000
G21.8 Other secondary Parkinsonism	0.004	0.995	0.000
G21.4 Vascular parkinsonism	0.004	0.995	0.000
G21.3 Postencephalitic Parkinsonism	0.004	0.995	0.000
G21.2 Secondary Parkinsonism due to other external agents	0.004	0.995	0.000
G21.1 Other drug-induced secondary Parkinsonism	0.004	0.995	0.000
G21.0 Malignant neuroleptic syndrome	0.004	0.995	0.000
G23.9 Degenerative disease of basal ganglia, unspecified	0.004	0.995	0.000
G23.8 Other specified degenerative diseases of basal ganglia	0.004	0.995	0.000
G23.3 Multiple system atrophy, cerebellar type	0.004	0.995	0.000
G23.2 Striatonigral degeneration	0.004	0.995	0.000
G23.1 Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]	0.004	0.995	0.000
G23.0 Hallervorden-Spatz disease	0.004	0.995	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.005	0.995	0.000
J84.9 Interstitial pulmonary disease, unspecified	0.005	0.995	0.000
X45 Accidental poisoning by and exposure to alcohol	0.005	0.995	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.005	0.995	0.000
X63.0 Home	0.005	0.995	0.000
G20 Parkinson's disease	0.000	0.995	0.005
G32.0 Subacute combined degeneration of spinal cord in diseases classified elsewhere	0.005	0.995	0.000
N83.7 Haematoma of broad ligament	0.000	0.995	0.005
N83.6 Haematosalpinx	0.000	0.995	0.005
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.000	0.995	0.005
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.005	0.995	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.995	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.005	0.995	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.005	0.995	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.005	0.995	0.000
Y51.0 Anticholinesterase agents	0.005	0.995	0.000
G80.8 Other infantile cerebral palsy	0.005	0.995	0.000
Y54.4 Loop [high-ceiling] diuretics	0.005	0.995	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
Y48.4 Anaesthetic, unspecified	0.005	0.995	0.000
X10-X19 Contact with heat and hot substances	0.005	0.995	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.005	0.995	0.000
G70-G73 Diseases of myoneural junction and muscle	0.005	0.995	0.000
G80.2 Infantile hemiplegia	0.004	0.995	0.000
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.005	0.995	0.000
Y56.9 Topical agent, unspecified	0.004	0.995	0.000
Y56.8 Other topical agents	0.004	0.995	0.000
Y56.7 Dental drugs, topically applied	0.004	0.995	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.004	0.995	0.000
Y56.5 Ophthalmological drugs and preparations	0.004	0.995	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.995	0.000
Y56.3 Emollients, demulcents and protectants	0.004	0.995	0.000
Y56.2 Local astringents and local detergents	0.004	0.995	0.000
Y56.1 Antipruritics	0.004	0.995	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.005	0.995	0.000
Y40.7 Antifungal antibiotics, systemically used	0.004	0.995	0.000
Y40.6 Rifamycins	0.004	0.995	0.000
Y40.5 Aminoglycosides	0.004	0.995	0.000
Y40.4 Tetracyclines	0.004	0.995	0.000
Y40.2 Chloramphenicol group	0.004	0.995	0.000
Y42.5 Other oestrogens and progestogens	0.005	0.995	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.004	0.995	0.000
G03.8 Meningitis due to other specified causes	0.004	0.995	0.000
G03.2 Benign recurrent meningitis [Mollaret]	0.004	0.995	0.000
G03.1 Chronic meningitis	0.004	0.995	0.000
G03.0 Nonpyogenic meningitis	0.004	0.995	0.000
G82.4 Spastic tetraplegia	0.004	0.995	0.000
X41.0 Home	0.004	0.995	0.000
X41.8 Other specified place	0.004	0.995	0.000
X41.7 Farm	0.004	0.995	0.000
X41.6 Industrial and construction area	0.004	0.995	0.000
X41.5 Trade and service area	0.004	0.995	0.000
X41.4 Street and highway	0.004	0.995	0.000
X41.3 Sports and athletics area	0.004	0.995	0.000
X41.2 School, other institution and public administrative area	0.004	0.995	0.000
X41.1 Residential institution	0.004	0.995	0.000
Y59.9 Vaccine or biological substance, unspecified	0.004	0.995	0.000
Y59.8 Other specified vaccines and biological substances	0.004	0.995	0.000
Y59.2 Protozoal vaccines	0.004	0.995	0.000
Y59.1 Rickettsial vaccines	0.004	0.995	0.000
Y59.0 Viral vaccines	0.004	0.995	0.000
F02 Dementia in other diseases classified elsewhere	0.004	0.995	0.000
Y54.9 Mineral salts, not elsewhere classified	0.004	0.995	0.000
Y54.7 Agents affecting calcification	0.004	0.995	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.004	0.995	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.004	0.995	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.004	0.995	0.000
Y54.0 Mineralocorticoids	0.004	0.995	0.000
Y10-Y34 Event of undetermined intent	0.004	0.995	0.000
G82.2 Paraplegia, unspecified	0.004	0.995	0.000
N83.3 Acquired atrophy of ovary and Fallopian tube	0.000	0.995	0.004
Y48.3 Local anaesthetics	0.004	0.995	0.000
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.000	0.995	0.004
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.995	0.000
F03 Unspecified dementia	0.004	0.995	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.004	0.995	0.000
W50-W64 Exposure to animate mechanical forces	0.004	0.995	0.000
W08.0 Home	0.004	0.996	0.000
Y48.2 Other and unspecified general anaesthetics	0.004	0.996	0.000
X00-X09 Exposure to smoke, fire and flames	0.004	0.996	0.000
G82.5 Tetraplegia, unspecified	0.004	0.996	0.000
V01-V09 Pedestrian injured in transport accident	0.004	0.996	0.000
Y48.5 Therapeutic gases	0.004	0.996	0.000
Y48.1 Parenteral anaesthetics	0.004	0.996	0.000
Y48.0 Inhaled anaesthetics	0.004	0.996	0.000
G93.8 Other specified disorders of brain	0.004	0.996	0.000
X42.9 Unspecified place	0.004	0.996	0.000
X42.0 Home	0.004	0.996	0.000
X42.8 Other specified place	0.004	0.996	0.000
X42.7 Farm	0.004	0.996	0.000
X42.6 Industrial and construction area	0.004	0.996	0.000
X42.5 Trade and service area	0.004	0.996	0.000
X42.4 Street and highway	0.004	0.996	0.000
X42.3 Sports and athletics area	0.004	0.996	0.000
X42.1 Residential institution	0.004	0.996	0.000
Y47.1 Benzodiazepines	0.004	0.996	0.000
G80.4 Ataxic cerebral palsy	0.004	0.996	0.000
G80.3 Dyskinetic cerebral palsy	0.004	0.996	0.000
G80.1 Spastic diplegia	0.004	0.996	0.000
G80.0 Spastic cerebral palsy	0.004	0.996	0.000
D36 Benign neoplasm of other and unspecified sites	0.000	0.996	0.004
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
G82.3 Flaccid tetraplegia	0.004	0.996	0.000
G82.0 Flaccid paraplegia	0.004	0.996	0.000
Q28 Other congenital malformations of circulatory system	0.004	0.996	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.004	0.996	0.000
G93.2 Benign intracranial hypertension	0.004	0.996	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
Y55.5 Anticommon cold drugs	0.004	0.996	0.000
Y55.4 Expectorants	0.004	0.996	0.000
Y55.3 Antitussives	0.004	0.996	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.004	0.996	0.000
Y55.0 Oxytocic drugs	0.004	0.996	0.000
F02.0 Dementia in Pick's disease	0.004	0.996	0.000
Y54.8 Agents affecting uric acid metabolism	0.004	0.996	0.000
W29 Contact with other powered hand tools and household machinery	0.004	0.996	0.000
W84 Unspecified threat to breathing	0.004	0.996	0.000
V90-V94 Water transport accidents	0.004	0.996	0.000
Y54.3 Benzothiadiazine derivatives	0.004	0.996	0.000
G06.0 Intracranial abscess and granuloma	0.004	0.996	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.004	0.996	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.004	0.996	0.000
Y47.4 Bromine compounds	0.004	0.996	0.000
Y47.3 Paraldehyde	0.004	0.996	0.000
Y47.2 Chloral derivatives	0.004	0.996	0.000
Y47.0 Barbiturates, not elsewhere classified	0.004	0.996	0.000
X84 Intentional self-harm by unspecified means	0.004	0.996	0.000
X83 Intentional self-harm by other specified means	0.004	0.996	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.004	0.996	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.004	0.996	0.000
X80 Intentional self-harm by jumping from a high place	0.004	0.996	0.000
X79 Intentional self-harm by blunt object	0.004	0.996	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.004	0.996	0.000
X76 Intentional self-harm by smoke, fire and flames	0.004	0.996	0.000
X75 Intentional self-harm by explosive material	0.004	0.996	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.004	0.996	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.004	0.996	0.000
X72 Intentional self-harm by handgun discharge	0.004	0.996	0.000
X71 Intentional self-harm by drowning and submersion	0.004	0.996	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.004	0.996	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.004	0.996	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.004	0.996	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
V98-V99 Other and unspecified transport accidents	0.004	0.996	0.000
Y35-Y36 Legal intervention and operations of war	0.004	0.996	0.000
X85-X99 Assault	0.004	0.996	0.000
X30-X39 Exposure to forces of nature	0.004	0.996	0.000
W65-W74 Accidental drowning and submersion	0.004	0.996	0.000
V95-V97 Air and space transport accidents	0.004	0.996	0.000
V70-V79 Bus occupant injured in transport accident	0.004	0.996	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.004	0.996	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.004	0.996	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.004	0.996	0.000
G06.2 Extradural and subdural abscess, unspecified	0.004	0.996	0.000
X49.09 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances; Home; During unspecified activity	0.004	0.996	0.000
X49.48 Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances; Street and highway;While engaged in other specified activities	0.004	0.996	0.000
Y00-Y09 Assault	0.004	0.996	0.000
Y50.9 Central nervous system stimulant, unspecified	0.004	0.996	0.000
Y50.8 Other central nervous system stimulants	0.004	0.996	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.004	0.996	0.000
Y50.1 Opioid receptor antagonists	0.004	0.996	0.000
Y50.0 Analeptics	0.004	0.996	0.000
Y58.9 Other and unspecified bacterial vaccines	0.004	0.996	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.004	0.996	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.004	0.996	0.000
Y58.5 Diphtheria vaccine	0.004	0.996	0.000
Y58.4 Tetanus vaccine	0.004	0.996	0.000
Y58.3 Plague vaccine	0.004	0.996	0.000
Y58.2 Cholera vaccine	0.004	0.996	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.004	0.996	0.000
Y58.0 BCG vaccine	0.004	0.996	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.004	0.996	0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.004	0.996	0.000
G31.0 Circumscribed brain atrophy	0.004	0.996	0.000
Y41.0 Sulphonamides	0.004	0.996	0.000
V18 Pedal cyclist injured in noncollision transport accident	0.004	0.996	0.000
W31 Contact with other and unspecified machinery	0.004	0.996	0.000
X78.9 Unspecified place	0.004	0.996	0.000
X78.8 Other specified place	0.004	0.996	0.000
X78.7 Farm	0.004	0.996	0.000
X78.6 Industrial and construction area	0.004	0.996	0.000
X78.5 Trade and service area	0.004	0.996	0.000
X78.4 Street and highway	0.004	0.996	0.000
X78.3 Sports and athletics area	0.004	0.996	0.000
X78.2 School, other institution and public administrative area	0.004	0.996	0.000
X78.1 Residential institution	0.004	0.996	0.000
W80 Inhalation and ingestion of other objects causing obstruction of respiratory tract	0.004	0.996	0.000
X10 Contact with hot drinks, food, fats and cooking oils	0.004	0.996	0.000
V19 Pedal cyclist injured in other and unspecified transport accidents	0.004	0.996	0.000
W45 Foreign body or object entering through skin	0.004	0.996	0.000
F02.8 Dementia in other specified diseases classified elsewhere	0.004	0.996	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.004	0.996	0.000
W23 Caught, crushed, jammed or pinched in or between objects	0.004	0.996	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.004	0.996	0.000
D36.0 Lymph nodes	0.000	0.996	0.004
G03.9 Meningitis, unspecified	0.004	0.996	0.000
G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere	0.004	0.996	0.000
G13.2 Systemic atrophy primarily affecting central nervous system in myxoedema	0.004	0.996	0.000
G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease	0.004	0.996	0.000
G13.0 Paraneoplastic neuromyopathy and neuropathy	0.004	0.996	0.000
W29.9 Unspecified place	0.004	0.996	0.000
O26 Maternal care for other conditions predominantly related to pregnancy	0.004	0.996	0.000
W08 Fall involving other furniture	0.004	0.996	0.000
G35-G37 Demyelinating diseases of the central nervous system	0.004	0.996	0.000
X69.0 Home	0.004	0.996	0.000
X40.9 Unspecified place	0.004	0.996	0.000
X40.0 Home	0.004	0.996	0.000
X40.8 Other specified place	0.004	0.996	0.000
X40.7 Farm	0.004	0.996	0.000
X40.6 Industrial and construction area	0.004	0.996	0.000
X40.5 Trade and service area	0.004	0.996	0.000
X40.4 Street and highway	0.004	0.996	0.000
X40.3 Sports and athletics area	0.004	0.996	0.000
X40.2 School, other institution and public administrative area	0.004	0.996	0.000
X40.1 Residential institution	0.004	0.996	0.000
X43.9 Unspecified place	0.004	0.996	0.000
X43.8 Other specified place	0.004	0.996	0.000
X43.7 Farm	0.004	0.996	0.000
X43.6 Industrial and construction area	0.004	0.996	0.000
X43.5 Trade and service area	0.004	0.996	0.000
X43.4 Street and highway	0.004	0.996	0.000
X43.3 Sports and athletics area	0.004	0.996	0.000
X43.2 School, other institution and public administrative area	0.004	0.996	0.000
X43.1 Residential institution	0.004	0.996	0.000
X43.0 Home	0.004	0.996	0.000
X44.9 Unspecified place	0.004	0.996	0.000
X44.0 Home	0.004	0.996	0.000
X44.8 Other specified place	0.004	0.996	0.000
X44.7 Farm	0.004	0.996	0.000
X44.6 Industrial and construction area	0.004	0.996	0.000
X44.5 Trade and service area	0.004	0.996	0.000
X44.4 Street and highway	0.004	0.996	0.000
X44.3 Sports and athletics area	0.004	0.996	0.000
X44.2 School, other institution and public administrative area	0.004	0.996	0.000
X44.1 Residential institution	0.004	0.996	0.000
X46.6 Industrial and construction area	0.004	0.996	0.000
X46.9 Unspecified place	0.004	0.996	0.000
X46.8 Other specified place	0.004	0.996	0.000
X46.7 Farm	0.004	0.996	0.000
X46.5 Trade and service area	0.004	0.996	0.000
X46.4 Street and highway	0.004	0.996	0.000
X46.3 Sports and athletics area	0.004	0.996	0.000
X46.2 School, other institution and public administrative area	0.004	0.996	0.000
X46.1 Residential institution	0.004	0.996	0.000
X46.0 Home	0.004	0.996	0.000
X48.9 Unspecified place	0.004	0.996	0.000
X48.8 Other specified place	0.004	0.996	0.000
X48.7 Farm	0.004	0.996	0.000
X48.6 Industrial and construction area	0.004	0.996	0.000
X48.5 Trade and service area	0.004	0.996	0.000
X48.4 Street and highway	0.004	0.996	0.000
X48.3 Sports and athletics area	0.004	0.996	0.000
X48.2 School, other institution and public administrative area	0.004	0.996	0.000
X48.1 Residential institution	0.004	0.996	0.000
X48.0 Home	0.004	0.996	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.004	0.996	0.000
W84.9 Unspecified place	0.004	0.996	0.000
W28 Contact with powered lawn mower	0.004	0.996	0.000
O26.2 Pregnancy care of habitual aborter	0.004	0.996	0.000
X63.9 Unspecified place	0.004	0.996	0.000
X63.8 Other specified place	0.004	0.996	0.000
X63.7 Farm	0.004	0.996	0.000
X63.6 Industrial and construction area	0.004	0.996	0.000
X63.5 Trade and service area	0.004	0.996	0.000
X63.4 Street and highway	0.004	0.996	0.000
X63.3 Sports and athletics area	0.004	0.996	0.000
X63.2 School, other institution and public administrative area	0.004	0.996	0.000
X63.1 Residential institution	0.004	0.996	0.000
G12 Spinal muscular atrophy and related syndromes	0.004	0.996	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.004	0.996	0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere	0.004	0.996	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations